Clovis Oncology Inc (NASDAQ:CLVS) shares climbed 7.45% to $61.00 in the pre-market trading session after the company reported that it has received breakthrough therapy designation for CO-1686. Clovis Oncology Inc (NASDAQ:CLVS) stock opened today at $60.21 and is currently trading at $59.82. The stock showed a positive weekly performance of 10.88%.
Ophthotech Corp. (NASDAQ:OPHT) announced after the bell Monday that its has entered into an ex-US licensing and commercialization agreement with Novartis Pharmaceuticals focused on the treatment of wet age-related macular degeneration. Ophthotech has granted Novartis exclusive rights to commercialize Fovista in markets outside the United States. Ophthotech Corp (NASDAQ:OPHT) stock opened at $38.33, in current trading session and currently is at $36.85, by gaining 16.82%. The 52 week range is $36.75 – $38.73. Company’s market capitalization is $1.23 billion.
Tarena International Inc (ADR) (NASDAQ:TEDU) posted its quarterly earnings results on Monday. The company reported $0.01 earnings per share for the quarter, meeting the analysts’ consensus estimate of $0.01, American Banking and Market Newsreports. The company had revenue of $24.30 million for the quarter, compared to the consensus estimate of $23.08 million. Tarena International Inc (ADR) (NASDAQ:TEDU) stock is currently trading at $8.20. The EPS of the stock is -0.57. Company’s market capitalization is $416.91 million.
Sonus Networks, Inc. (NASDAQ:SONS), a global leader in SIP communications, today announced that TMC, a global, integrated media company, has named the Sonus SBC SWe a 2014 Excellence in SDN Award winner presented by TMC’s INTERNET TELEPHONY Magazine and SDN Zone. The SBC SWe received this award based on its leadership in the SDN technology domain. Sonus Networks, Inc. (NASDAQ:SONS) stock opened the session at $3.35, and now is at $3.27. The 52 week range of the GOOG stock remained $3.24 – $3.98 and the day range was $3.24 – $3.35.
Research analysts at Credit Suisse raised their target price on shares of Smith & Wesson Holding Corp (NASDAQ:SWHC) from $13.00 to $20.00 in a report released on Tuesday. The firm currently has a “buy” rating on the stock. Credit Suisse’s price objective would suggest a potential upside of 32.63% from the company’s current price. Smith & Wesson Holding Corp (NASDAQ:SWHC) stock opened today at $15.46 and is currently trading at $15.48. The stock showed a negative weekly performance of -5.81%.
Leave a Reply